CA
NZ
UK
AU
IND
US
Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) is reported as beneficially owned at 54.6% by Celadon Partners SPV 24, Celadon Partners, LLC and CPIF II-7 Limited. The reported position covers 25,748,890 shares of common stock and is identified as activist under Schedule 13D. The position …
INTUITIVE SURGICAL INC (NASDAQ: ISRG) executive Mark Brosius sold 48 shares across two transactions priced from $347.66 to $365.79 per share. The transactions took place on 10 September 2026 and 11 September 2026. The sales were made by Brosius in his role as EVP …
KAMADA LTD (NASDAQ: KMDA) director Tsur David sold 177,173 shares across three transactions at prices ranging from $8.26 to $8.28 per share. The sales took place between Sep. 7 and Sep. 9, 2026, while David retained 430,756 shares after the transactions.
Metagenomi Therapeutics, Inc. (NASDAQ: MGX) insider Reid Laurence bought 20,000 shares in separate transactions. The purchases occurred at prices between $1.17 and $1.18 per share.
Omada Health, Inc. (NASDAQ: OMDA) Chief Accounting Officer Gracey Craig sold 644 shares at $21.73 per share. The transaction occurred on 9 September 2026.
INSMED Inc (NASDAQ: INSM) director Brennan David R sold 25,000 shares at $124 per share on Sep. 9, 2026.
The company is pursuing a new manufacturing run after its analysis found structural differences between product batches used in different clinical studies.
ELI LILLY & Co (NYSE: LLY) executive Melissa Seymour transferred 29 shares at $0 per share across two transactions, leaving her with 1,038 shares. The transactions covered the period from September 22, 2025, through September 9, 2026.
GILEAD SCIENCES, INC. (NASDAQ: GILD) Chief Medical Officer Berger Dietmar’s option exercise left him with 19,785 shares on Sep. 10, 2026. The transaction represented about 2.7% of his resulting shareholding. A separate transaction on the same date reduced his reported holding to 19,522 shares. …
GILEAD SCIENCES, INC. (NASDAQ: GILD) CEO Daniel Patrick O’Day exercised options for 8,780 shares on 10 September 2026, leaving him with 585,913 shares after the transaction. The filing also records a forfeiture of shares and an exercise involving derivative securities.
Please wait processing your request...